Literature DB >> 18755462

Complement C3 and C-reactive protein in male survivors of myocardial infarction.

Angela M Carter1, Usha K Prasad, Peter J Grant.   

Abstract

BACKGROUND: Inflammatory processes play a fundamental role in the development of cardiovascular disease.
OBJECTIVES: To compare the associations of complement C3 and C-reactive protein (CRP) with myocardial infarction (MI) and cardiovascular risk factors.
METHODS: 342 Caucasian male subjects aged < or =65 years with MI and 193 Caucasian age matched healthy male control subjects were recruited. C3 and CRP were measured by ELISA.
RESULTS: C3 and CRP were significantly higher (p<0.001) in patients compared with healthy subjects (patients vs. healthy subjects, C3: 1.22gL(-1) vs. 1.00gL(-1); CRP: 1.41mgL(-1) vs. 0.72mgL(-1)). In a logistic regression model, including conventional cardiovascular risk factors, C3 was independently associated with MI (odds ratio for a 1 S.D. increase in C3: 2.29 [1.58, 2.92]); and this association remained after including CRP and/or fibrinogen in the model. CRP was independently associated with MI after accounting for conventional risk factors (odds ratio for a 1 S.D. increase in CRP: 1.47 [1.16, 1.87]), however, this association was lost when C3and/or fibrinogen were included in the model. Receiver operating characteristic (ROC) analysis indicated that the model which best predicted MI was the model including C3 and fibrinogen.
CONCLUSIONS: These data suggest that elevated C3 is independently associated with MI and that elevated C3 may be a more specific marker of the inflammatory processes underpinning MI than CRP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18755462     DOI: 10.1016/j.atherosclerosis.2008.07.007

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  12 in total

1.  Enhancing complement control on endothelial barrier reduces renal post-ischemia dysfunction.

Authors:  Sathnur B Pushpakumar; Gustavo Perez-Abadia; Chirag Soni; Rong Wan; Nathan Todnem; Phani K Patibandla; Tathyana Fensterer; Qunwei Zhang; John H Barker; Claudio Maldonado
Journal:  J Surg Res       Date:  2011-07-07       Impact factor: 2.192

2.  Serum complement C3 has a stronger association with insulin resistance than high sensitive C-reactive protein in non-diabetic Chinese.

Authors:  Bangqiong Wang; Qifu Li; Yuanjuan Jiang; Zhoujun Liu; Li Zhong; Rong Luo; Qingfeng Cheng; Hua Qing
Journal:  Inflamm Res       Date:  2010-08-13       Impact factor: 4.575

3.  Predictors of progression in atherosclerosis over 2 years in systemic lupus erythematosus.

Authors:  Adnan N Kiani; Wendy S Post; Laurence S Magder; Michelle Petri
Journal:  Rheumatology (Oxford)       Date:  2011-08-28       Impact factor: 7.580

4.  Plasma Complement Protein C3a Level Was Associated with Abdominal Aortic Calcification in Patients on Hemodialysis.

Authors:  Yaqin Wang; Yuanyi Miao; Kunjing Gong; Xuyang Cheng; Yuqing Chen; Ming-Hui Zhao
Journal:  J Cardiovasc Transl Res       Date:  2019-04-15       Impact factor: 4.132

Review 5.  The role of complement activation in atherogenesis: the first 40 years.

Authors:  Sonia I Vlaicu; Alexandru Tatomir; Violeta Rus; Armugam P Mekala; Petru A Mircea; Florin Niculescu; Horea Rus
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

6.  Influence of hypertension, obesity and nicotine abuse on quantitative and qualitative changes in acute-phase proteins in patients with essential hypertension.

Authors:  Maciej Cymerys; Paweł Bogdański; Danuta Pupek-Musialik; Anna Jabłecka; Jan Łącki; Izabela Korczowska; Joanna Dytfeld
Journal:  Med Sci Monit       Date:  2012-05

7.  Plasma protein profiling reveals protein clusters related to BMI and insulin levels in middle-aged overweight subjects.

Authors:  Susan J van Dijk; Edith J M Feskens; A Geert Heidema; Marieke B Bos; Ondine van de Rest; Johanna M Geleijnse; Lisette C P G M de Groot; Michael Müller; Lydia A Afman
Journal:  PLoS One       Date:  2010-12-23       Impact factor: 3.240

8.  Human complement receptor type 1 (CR1) protein levels and genetic variants in chronic Chagas Disease.

Authors:  Thaisa Lucas Sandri; Kárita Cláudia Freitas Lidani; Fabiana Antunes Andrade; Christian G Meyer; Peter G Kremsner; Iara J de Messias-Reason; Thirumalaisamy P Velavan
Journal:  Sci Rep       Date:  2018-01-11       Impact factor: 4.379

9.  A novel mechanism for hypofibrinolysis in diabetes: the role of complement C3.

Authors:  K Hess; S H Alzahrani; M Mathai; V Schroeder; A M Carter; G Howell; T Koko; M W J Strachan; J F Price; K A Smith; P J Grant; R A Ajjan
Journal:  Diabetologia       Date:  2011-09-15       Impact factor: 10.122

Review 10.  Complement activation: an emerging player in the pathogenesis of cardiovascular disease.

Authors:  Angela M Carter
Journal:  Scientifica (Cairo)       Date:  2012-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.